It’s never too late to invest in explosive growth stocks

A lot of investors seem to think that just because a share has done well means it wouldn’t be a good investment.

If you take that attitude you could miss out on some serious gains.

Think how much Apple, Alphabet (Google), Facebook, Microsoft and Amazon had grown by up to 2013 and yet they have been some of the best performers in the global share market since 2013. Investors shouldn’t be afraid of investing in BETANASDAQ ETF UNITS (ASX: NDQ).

The same should be said of some ASX growth shares. Altium Limited (ASX: ALU) was obviously a great buy at $0.09 in July 2011. It may have seemed very expensive at around $13 in November 2017, yet a few months later it’s $19.26.

a2 Milk Company Ltd (ASX: A2M) is another example. There was a huge craze surrounding the a2 protein company in late 2015 when supermarket shelves were being stripped bare when the share price was at $1.88. Yet it kept going and going to $8.59 just before reporting season. Now it’s up to $11.60.

Great companies executing on their strategy don’t usually suddenly turn into rubbish companies. They keep on going.

That’s why I’m not afraid of investing in growth shares like REA Group Limited (ASX: REA), Costa Group Holdings Ltd (ASX: CGC), Appen Ltd (ASX: APX) and Ramsay Health Care Limited (ASX: RHC).

Foolish takeaway

Of course, you still need to be comfortable with the value you are investing at but it’s very likely they can grow into their valuation. I think this is a much better idea than trying to catch a falling knife that could just keep falling. Growth stocks are the way to go.

That’s why I’m very happy to have one of these top stocks in my portfolio.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of Altium and Ramsay Health Care Limited. The Motley Fool Australia owns shares of and has recommended BETANASDAQ ETF UNITS and COSTA GRP FPO. The Motley Fool Australia owns shares of A2 Milk, Altium, and Appen Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited and REA Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!